CJC-1295/Ipamorelin Blend (CJC-1295 (without DAC), Ipamorelin) Dosage Guide, Benefits & Side Effects

Frequently reported effects include injection-site reactions (redness, swelling, or soreness), transient flushing or warmth, mild headache, temporary fatigue, and some water retention or puffiness, especially early in use. These are generally described as mild and as diminishing within the first 1–4 weeks. Because Ipamorelin is selective for the ghrelin receptor, it is reported to avoid the larger cortisol/prolactin increases and appetite spikes associated with older, less-selective GHRPs. These reports come from user and clinic sources rather than controlled human safety trials, so the full risk profile of this specific unapproved combination has not been formally established.

General guidance describes reconstituting lyophilized (freeze-dried) peptide powder with bacteriostatic water injected slowly down the inside wall of the vial to avoid foaming/damaging the peptide, then gently swirling (not shaking) to dissolve. Unreconstituted vials are commonly stored frozen or refrigerated and are said to remain stable for roughly 1–2 years; once reconstituted, the solution is typically kept refrigerated (about 2–8°C) and used within roughly 30–45 days, avoiding repeated freeze-thaw cycles. Exact stability depends on the specific product and manufacturer instructions, which should take precedence over general guidance.

No FDA-approved drug product exists under this name. Both CJC-1295 and Ipamorelin are unapproved investigational compounds. As of late 2024/2026 reporting, the FDA's Pharmacy Compounding Advisory Committee voted against including either peptide on the list that would allow 503A pharmacy compounding, meaning there is currently no recognized U.S. compounding pathway for them. Consequently, most supply is sold as 'research chemical' product not intended for human consumption, and purity, sterility, and labeled content are not independently verified or regulated the way an approved drug would be. Buyers should treat any human-use claims from such sellers with caution.

Online sources and clinics commonly associate this combination with goals such as increased lean muscle mass, reduced body fat, improved sleep quality, and general anti-aging or recovery support, based on its role in stimulating endogenous growth hormone release. These are claims made by vendors, clinics, and user communities rather than findings from large, controlled clinical trials in the approved-drug sense, and the compound is not approved by regulators for any of these uses in humans.